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ABSTRACT
Objectives: It is controversial whether pelvic organ prolapse and stress urinary incontinence (SUI) should be treated 
simultaneously with a single surgery or separately with two procedures. The pre-pubic four-arm NAZCA-TC® mesh was 
invented to treat cystocele and SUI with a single procedure. The objective of this study is to analyze short-term results 
after the implantation of NAZCA-TC mesh. 
Material and methods: A total of 18 women underwent the evaluation of results of mesh implantation within a 24 to 
36 months follow-up. Pre-operatively, patients were examined under standardized conditions. Postoperatively we analyzed 
the following: standardized interview and examination as well as pelvic floor ultrasound: 2D with a transvaginal probe and 
4D with an abdominal probe. 
Results: There was one case of intraoperative bladder damage noticed and repaired followed with NAZCA implantation. 
In 2 cases vaginal erosion was found that healed successfully after re-operation. In 3 cases hematomas were observed but 
resolved spontaneously. After the surgery there was a statistically significant improvement of prolapse in anterior (p < 0.0003) 
and in central (p < 0.001) compartment. Six women (33.3%) had no stress urinary incontinence symptoms during the control 
visit but we did not find a statistically significant improvement in SUI symptoms after the procedure. We recorded no case 
of hypomobile urethra after the surgery. The mesh covered > 50% of the urethral length in all of the patients.
Conclusions: Mid-term results showed that implantation of NAZCA TC mesh allows to achieve statistically significant im-
provement in reducing cystocele coexisting with enterocele in over 65% of patients. A complete cure from stress urinary 
incontinence was confirmed in 1/3 of patients. NAZCA-TC covered more than 50% of the urethral length, which can possibly 
have a negative influence on the effectiveness of the suburethral tape.
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INTRODUCTION
Stress urinary incontinence (SUI) is the most common 
type of urinary incontinence in women [1–4]. SUI and pelvic 
organ prolapse (POP) are often the reasons for operative 
treatment, especially in ageing populations [5–11]. There 
are no recommendations regarding an optimal surgical 
intervention in different clinical situations. Thus, controver-
sies may arise in a situation where POP coexists with overt 
or occult SUI. In such case the question is whether POP and 
coexisting SUI should be addressed together at one proce-
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dure or not. While occult incontinence may coexist in up 
to 30% of women with POP, about 40–50% of women with 
POP observe a significant SUI [12, 13]. NAZCA-TC is a mesh 
with four arms: two pre-pubic and two transobturator. It 
was invented to treat anterior vaginal wall prolapse alone 
or together with SUI [12].
The polypropylene mesh and its arms are well visible 
during pelvic floor ultrasound. That is why many specialists 
advocate the use of sonography to control the effects after 
urogynecological procedures where such slings are used [14]. 
Introital pelvic floor sonography with a transvaginal probe 
(PFS-TV) was previously used to evaluate patients with SUI 
before and after anti-incontinence suburethral sling implan-
tation [15, 16]. It was also found useful to evaluate POP and 
mesh used for treating it with a 2D or 4D pelvic floor ultra-
sound performed perineally with a transabdominal probe 
(PFU-TA) [14]. 
Urethral hypomobility was found to be one of the risk 
factors for failure of the implanted anti-incontinence sub-
urethral tape. PFS-TV in turn was found to be very useful in 
detecting hypomobility of the urethra [15, 16]. 
In patients who had two tapes implanted, a collision 
phenomenon between 2 anti-incontinence suburethral ta-
pes was observed during PFS-TV examination [17, 18]. That 
is why the literature suggests that the tape located near the 
middle part of the urethra be first excised and a new tape 
be implanted a few weeks later [17–19]. Because NAZCA-TC 
is implanted near the urethra, it would be valuable to check 
its location along the urethra and to evaluate its influence 
on the urethral mobility. 
In the literature there is only one study that analyzes the 
influence of NAZCA-TC implantation on SUI [12]. There are 
no studies concerning NAZCA-TC evaluation using PFS-TV 
or PFU-TA. 
OBJECTIVES 
The objective of this study is to evaluate the results 
of NAZCA-TC mesh implantation in women with POP and 
coexisting SUI symptoms using PFS-TV and PFU-TA.
MATERIAL AND METHODS 
NAZCA-TC® mesh (by Promedon, Argentina) was implan-
ted in 21 patients. The mesh is made of type I polypropylene 
monofilament with a density of 60.5 [g/m2]. The mesh pore 
size is 0.5–1 [mm], the mesh thickness is 0.47 [mm] and 
the filament diameter is 0.14 [mm]. The central part of the 
sling has 16 circular orifices with 6 [mm] in diameter each, 
which enhances tissue integration and decreases the amo-
unt of synthetic material implanted allowing thus a greater 
flexibility. The sling has 2 arms — two pre-pubic and two 
transobturator. One pre-pubic and two transobturator ne-
edles with removable and ergonomic handles complete 
the set [12]. All operated women had symptoms of SUI and 
a cystocele of stage 2 or higher as per Pelvic Organ Prolapse 
Quantification (POP-Q) system [9, 10, 20]. 
One and the same experienced surgeon (T.K.) performed 
the surgery on all the patients in the study. The data has 
been obtained retrospectively from a total of 18 patients 
who attended the control visit between 24 and 36 months 
following the procedure.
Pre-operatively, patients were examined under standar-
dized conditions. Pelvic organ prolapse (POP) was classified 
in accordance with POP-Q system [20]. SUI was confirmed 
by a cough test [21].
The surgery and mesh implantations were performed 
according to the technique described by Palma et al. [12]. 
When it comes to the postoperative analysis, we inclu-
ded the following: standardized interview and examination 
that includes analysis of POP using POP-Q scale; urinary con-
tinence evaluated with a cough test and a PFS-TV — a stan-
dardized pelvic floor ultrasound using GE Voluson Expert: 
2D introitally with a transvaginal probe (PFS-TV) and 4D 
translabially with an abdominal probe (PFU-TA). 
The volume of urine in the bladder was evaluated du-
ring transabdominal ultrasound by performing three-plane 
measurements of the bladder calculated by the ultrasound 
system. We have evaluated urinary incontinence in patients 
with 250–350 [ml] of urine in the bladder. PFS-TV was per-
formed under standardized conditions [15, 22, 23]. Cough 
test was performed in patients in lithotomy position. If the 
test was negative, it was repeated in standing. 
During the post-operative visit urethral length, mobility 
and funneling with urine flow was evaluated with PFS-TV 
on a sagittal view as previously described [15, 22–26]. The 
urethral mobility was evaluated as a vector calculated from 
measurements obtained during PFS-TV according to the 
method described by Viereck. This parameter is also called 
a linear dorsocaudal movement (LDM) [15, 24]. The urethra 
was defined as hypomobile when the value of the vector 
was ≤ 5 [mm], normomobile when more than 5 [mm] but 
less than 15 [mm] and hypermobile when ≥15 [mm] [15, 23]. 
The urethral funneling with a urine flow, which was obse-
rved during Valsalva maneuver in PFS-TV, was regarded as 
a confirmation of SUI that was previously recorded with 
a positive cough test [25, 26]. We diagnosed no SUI when 
there were no clinical symptoms or when SUI was observed 
by the patient only periodically while sitting and standing 
cough test and PFS-TV examination were all negative. A first 
degree of SUI was diagnosed when the patient reported SUI 
symptoms to be periodical (from time to time, not every day) 
and the cough test as well as SUI during PFS-TV exam were 
positive. A 2+ degree of SUI was diagnosed when patients 
reported to have symptoms every day and the cough test 
was positive, which had to be confirmed during PFS-TV.
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The location of urethral end of NAZCA-TC mesh was 
measured during PFS-TV on a sagittal view similarly to the 
measurements proposed by Kociszewski et al. for the sub-
urethral tape [15, 23]. We measured the shortest distance 
between the mesh and the hypoechoic urethra. It was called 
mesh-urethra distance measured in [mm] (Figure 1). We 
calculated the mesh position relative to the urethral length 
in % according to the formula (1):
Relative mesh position = distance of the distal end of 
the mesh from the bladder neck*100%/sonographic urethral 
length (Figure 1).
PFU-4D was performed under standardized condi-
tions. Hiatal dimensions at rest and during maximal Valsalva 
lasting minimum 5 seconds were measured in the plane of 
minimal hiatal dimensions, as described previously. Levator 
trauma was identified by tomographic ultrasound (TUI) as 
described previously [14, 27–28]. 
The statistical analysis was performed with STATISTICA 
7.0 software of Stat Soft. The calculations of median, arith-
metic mean and standard deviation were done. Student’s 
t-test was applied for testing the significance of differences 
for the dependent variables.
RESULTS
All 18 patients had the implantation of NAZCA mesh in 
a single procedure and it was their only treatment proce-
dure. The mean age of women was 62 years (range, 40–78). 
The mean BMI was 29.2 [kg/cm2] (range, 22.2–38.0). There 
were no statistically significant differences between SUI 
cured and not-cured in age and BMI. Three women were 
premenopausal, the rest were 3 to 24 years after meno-
pause (Table 1). One patient was taking insulin because of 
diabetes and 9 patients had hypertension. Four women were 
smoking > 10 cigarettes daily. One patient had a vacuum-
-assisted delivery, 3 patients had spontaneous deliveries 
and 1 patient had 3 spontaneous deliveries and a caesa-
rean section. The rest delivered only vaginally from 1 to 7 ti-
mes (mean = 3). Patients’ first baby was delivered between 
the age of 19 and 35 (mean = 23.3). One woman had an ab-
dominal hysterectomy in the history (leiomyomas) and one 
had a hysterectomy with bilateral salpingo-oophorectomy 
because of a benign ovarian tumor. None of the patients 
had a previous urogynecological surgery.
All of the patients had a cystocele of at least 2nd degree 
(POP-Q scale) confirmed during the preoperative examina-
tion. Additionally, an enterocele of 2nd degree was found 
in 5 patients and of 1st degree in 9 patients. In 7 cases exa-
mination revealed a rectocele of (patients with enteroce-
le 1+). After the NAZCA implantation the prolapse improved 
significantly in both the anterior (p < 0.0003) and central 
(p < 0.001) compartment. In the posterior compartment the 
differences were not statistically significant. At the control 
visit a POP of 2nd degree was noticed in 6 patients in the an-
terior compartment, in 1 patient in the central compartment 
and in 1 patient in the posterior compartment (Table 2). Only 
2 patients (11.1%) did not notice any significant improve-
ment of POP symptoms. 
Before the surgery all of the patients suffered from SUI 
2nd degree that was confirmed during cough test. There was 
no statistically significant improvement in SUI symptoms 
after the NAZCA implantation. Although 8 patients (44.4%) 
observed symptoms to disappear or subside, 5 (27.8%) re-
ported no change and other 5 (27.8%) reported the symp-
Figure 1. PFS-TV: evaluating mesh location. A. Evaluating relative 
mesh position. Legend: 1+2 — urethral length; 3 — projection of 
distal end of the mesh on urethral axis; 4 + 1 — distance between 
distal end of the mesh and bladder neck (internal urethral orifice); 
Bl — bladder; U — urethra; S — symphysis pubis; relative mesh 
position = 1 + 2/4 + 1 × 100%; B. Evaluating mesh-urethra distance. 
Legend: 1 and 2 — distances between mesh and hypoechoic urethra, 
mesh urethra distance is the smallest distance between tape and 
hypoechoic urethra: in this case measurement No. 2; Bl — bladder; 
U — urethra; S — symphysis pubis
A
B
Table 1. Demographic data of the studied group
Mean age of women (min–max) 62.0 years (40–78)
Mean BMI (min–max) 29.2 [kg/cm2] (22.2–38.0)
Number of premenopausal women 3
Number of postmenopausal women 15
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toms to worsen. Only 6 patients (33.3%) had no stress uri-
nary incontinence symptoms at the control visit, of which 
2 reported a periodical SUI despite a negative cough test 
and no signs of SUI during PFS-TV. The rest suffered from 
SUI 2nd degree.
Preoperatively, symptoms of dry overactive bladder 
were reported by 61.1% of patients. After the surgery 72.2% 
of them noticed a significant improvement. There was no 
case of urge de novo or wet overactive bladder.
Pelvic floor ultrasound revealed the mesh to be rolled 
up in 11 cases (61.1%) (Figure 2). 
Mean urethral length in SUI cured and not-cured pa-
tients was nearly the same: 2.97 cm vs. 2.99 cm (NS). PFS-TV 
showed that the mesh was covering more than 50% of the 
urethral length in all of the patients and 75% of the length 
in 72.2% of patients (Figure 2). The mean relative mesh po-
sition was 80.3% (range, 55.6–94.1%): in SUI cured group: 
79,8%, in SUI not-cured group: 80,1% (NS). The mean mesh-
-urethra distance was 4.40 [mm] (range, 0.18–7.50), in SUI 
cured group: 4,4 mm, in SUI not-cured group: 4,5 mm (NS). 
After the NAZCA implantation there was no patient with 
a hypomobile urethra. PFS-TV showed a hypermobile urethra 
in 12 patients (66.7%) and a normomobile urethra in 6 patients 
(33.3%). The mean LDM value was 19.3 [mm] (range, 6.1–31.4). 
The differences in mean LDM between SUI cured group and 
SUI not-cured group were not statistically significant.
PFU-4D revealed that the mean hiatal area was 23.5 cm2 
 (15.6–39.0) at rest and 28.4 cm2 (18.1–47.1) at maximal Val-
salva. In 3 patients (16.7%) a unilateral puborectalis avulsion 
was identified. 72.2% of patients were at increased risk of 
postoperative POP recurrence due to hiatal area > 25 [cm2] 
and/or levator avulsion. In SUI cured group mean hiatal area at 
rest was 24.0 cm2 and during maximal Valsalva — 29.2 cm2, in 
SUI not cured group respectively 22.3 cm2 and 26.7 cm2 (NS).
Bladder damage has occurred in one patient that 
was found intraoperatively. It was repaired followed with 
NAZCA implantation. Vaginal erosion was noticed in 2 cases 
(11.1%) and after re-operation it was successfully healed. The 
erosions were identified among smokers only. In 5 women 
(27.8%) we noted a post-void residual > 100 mL, which 
lasted < 7 days. In 3 women (16.7%) hematomas were detec-
ted but resolved spontaneously. In 5 cases (27.8%) infection 
of urinary tract has occurred soon after the surgery.
A total of 3 patients did not attend the control visit but 
NAZCA implantation and hospitalization was complications 
free.
DISCUSSION
The pathophysiology of SUI is not fully understood. 
Recently, it has been claimed that urethral hypermobility 
and sphincter weakness called intrinsic sphincter deficiency 
can explain SUI in most of the cases [14, 29–31]. 
Suburethral tapes are highly successful in treating SUI 
but the mechanism of their action as well the reasons for 
eventual failure remain quite unknown. Urethral hypomo-
bility is a generally accepted risk factor for failure. There are 
studies using PFS-TV showing that the relative tape position, 
the tape-urethra distance and the urethral mobility toge-
Table 2. POP-Q evaluation before and after the NAZCA implantation
Preoperative examination Postoperative examination p value
Cystocele of at least 2nd degree 15 6 p < 0.0003
Enterocele of at least 2nd degree 5 1 p < 0.001
Rectocele of at least 2nd degree 0 1 Not statistically significant
Figure 2. PFS-TV: NAZCA mesh, covering nearly the whole length of 
the urethra. A. Rolled-up; B. Without signs of rolling
A
B
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ther have a definitive impact on the cure rate [15, 22, 23]. 
However, Dietz et al., using PFU-TA, was not able to confirm 
the results obtained during PFS-TV [32].
POP is a common female disease [33]. It often co-exists 
with overt SUI or occult SUI. It is still not clear if combining 
the treatment of POP and SUI to one procedure is an optimal 
choice. Yet, compared to anterior mesh procedure where 39–
–77% of women became free of SUI symptoms, combining 
anterior mesh with a suburethral tape implantation gave 
a 78–95% cure rate. However, the incidence of complications 
was significantly higher after a combined procedure [13, 34]. 
The study of Palma et al. evaluates a total of 104 women 
who had NAZCA TC implantation, of which 31 had POP co-
existing with SUI pre-operatively. Only two of them (6.5%) 
report treatment failure after 12 months follow-up [12]. 
In the study of Delroy et al. 79 women underwent either 
a classic anterior repair or a method using NAZCA TC but 
urinary incontinence was not analyzed in that study [35]. 
In our population in turn, the objective cure rate from SUI 
was 33%. Subjective cure or satisfactory improvement was 
expressed by 44% of the patients. Yet, it is not clear why the 
difference between our results and those of Palma’s is so 
big. It might be that the reason lies in the differences in the 
operating technique or in the very population of patients.
Two available studies concerning NAZCA TC report 
5.0–5.7% cases of erosions, 4.0–4.5% cases of increased 
bleeding and 5–6% of patients with post-void residual 
lasting < 7 days. A urethral perforation happened in up 
to 2.5% of procedures, while bladder perforation in 0% 
of cases. Urinary tract infections (UTI’s) were noticed by 
20% of patients. A statistically significant improvement was 
observed in all compartments but additional procedure 
for posterior or central compartment in more than 50% of 
women had to be performed [12, 35].
Compared to the two studies mentioned above, the risk 
of complications in our population was similar. We did not 
record a statistically significant improvement in the poste-
rior compartment since our patients had the anterior mesh 
implantation as the only procedure. It is worth highlighting 
that although 72.2% of patients were at a higher risk of 
postoperative POP recurrence (hiatal area > 25 cm2 and/or 
levator avulsion), 24–36 months following the procedure we 
confirmed a statistically significant improvement of prolapse 
in both the anterior and central compartment.
We did not find a negative influence of the sling on the 
urethral mobility, as there was no case of hypomobility after 
NAZCA TC implantation. In some cases the mesh-urethra 
distance was less than 3 [mm] but we did not notice urge de 
novo in these patients. Kociszewski et al. observed a higher 
risk of urge de novo in cases of suburethral tape implanta-
tion when the tape-urethra distance was < 3 [mm] [22, 23]. 
The mesh was covering more than 50% of the urethral 
length in 100% of our patients and 75% of the length in 
72.2% of patients. This may theoretically be the reason for 
the collision between mesh and suburethral tape, which 
may complicate the SUI cure after the tape implantation [17, 
18]. Therefore, it would be interesting to analyze the effects 
of suburethral tape implantation in women with persistent 
SUI after NAZCA TC implantation.
There exist some limitations of our study. The analysis 
was retrospective and the ultrasound scan was performed 
after the surgery only. Also, we did not use standardized 
questionnaires for the evaluation. On the other hand, one 
and the same experienced surgeon performed all of the 
NAZCA implantations and the results were objectively eva-
luated using a clinical, PFS-TV and PFU-TA examination. 
The results of our study suggest the need to perform some 
prospective randomized studies confronting comparatively 
the transobturator mesh with and without a simultaneous 
suburethral sling implantation.
CONCLUSIONS
Mid-term results showed that implantation of NAZCA 
TC mesh allows to achieve statistically significant improve-
ment in reducing cystocele coexisting with enterocele in 
over 65% of patients. A complete cure from stress urinary 
incontinence was confirmed in 1/3 of patients. NAZCA TC 
covered more than 50% of the urethral length, which can po-
ssibly have a negative influence on the effectiveness of the 
suburethral tape.
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